Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases, first results from a phase III randomized controlled multicenter trial (the SCANDIUM trial).

被引：0
|
作者：
Bagge, Roger Olofsson
Nelson, Axel
Shafazand, Amir
All-Ericsson, Charlotta
Cahlin, Christian
Elander, Nils
Helgadottir, Hildur
Kiilgaard, Jens Folke
Kinhult, Sara
Ljuslinder, Ingrid
Rizell, Magnus
Eilard, Malin Sternby
Ullenhag, Gustav J.
Nilsson, Jonas A.
Ny, Lars
Lindner, Per
机构：
[1] Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden
[2] Univ Gothenburg, Dept Oncol, Inst Clin Sci, Sahlgrenska Acad,Sahlgrenska Univ Hosp, Gothenburg, Sweden
[3] Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Ctr Canc Res, Dept Surg,Inst Clin Sci, Gothenburg, Sweden
[4] Karolinska Inst, St Erik Eye Hosp, Stockholm, Sweden
[5] Univ Gothenburg, Transplant Inst, Inst Clin Sci, Sahlgrenska Univ Hosp,Sahlgrenska Acad, Gothenburg, Sweden
[6] Linkoping Univ Hosp, Dept Oncol, Linkoping, Sweden
[7] Karolinska Univ Hosp, Stockholm, Sweden
[8] Copenhagen Univ Hosp Glostrup, Glostrup Hosp, Dept Ophthalmol, Copenhagen, Denmark
[9] Onkol Kliniken, Lund, Sweden
[10] Norrlands Univ Hosp, Dept Oncol, Umea, Sweden
[11] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Sect Oncol, Uppsala, Sweden
[12] Univ Western Australia, Harry Perkins Inst Med Res, Perth, WA, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA9509
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Randomized phase III trial of intravenous (IV) versus hepatic intra-arterial (HIA) fotemustine in patients with liver metastases from uveal melanoma: Final results of the EORTC 18021 study
    Leyvraz, Serge
    Suciu, Stefan
    Piperno-Neumann, Sophie
    Baurain, Jean-Francois
    Zdzienicki, Marcin
    Testori, Alessandro
    Marshall, Ernest
    Scheulen, Max E.
    Jouary, Thomas
    Negrier, Sylvie
    Vermorken, Jan Baptist
    Kaempgen, Eckhart
    Durando, Xavier
    Schadendorf, Dirk
    Gurunath, Ravichandra Karra
    Polders, Larissa
    De Schaetzen, Gaetan
    Vanderschaeghe, Simon
    Gauthier, Marie-Pierre
    Keilholz, Ulrich
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [22] Treating unresectabel liver metastases of uveal melanoma with (percutaneous) isolated hepatic perfusion with melphalan: Results from two experienced centers
    De Leede, E. M.
    Burgmans, M. C.
    Kapiteijn, H. W.
    Martini, C. H.
    Tijl, F. G. J.
    Vuyk, J.
    Hartgrink, H. H.
    Van Erkel, A. R.
    Van de Velde, C. J. H.
    Verhoef, C.
    Vahrmeijer, A. L.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S415 - S415
  • [23] Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)
    Carvajal, Richard D.
    Piperno-Neumann, Sophie
    Kapiteijn, Ellen
    Chapman, Paul B.
    Frank, Stephen
    Joshua, Anthony M.
    Piulats, Josep M.
    Wolter, Pascal
    Cocquyt, Veronique
    Chmielowski, Bartosz
    Evans, T. R. Jeffry
    Gastaud, Lauris
    Linette, Gerald
    Berking, Carola
    Schachter, Jacob
    Rodrigues, Manuel J.
    Shoushtari, Alexander N.
    Clemett, Delyth
    Ghiorghiu, Dana
    Mariani, Gabriella
    Spratt, Shirley
    Lovick, Susan
    Barker, Peter
    Kilgour, Elaine
    Lai, Zhongwu
    Schwartz, Gary K.
    Nathan, Paul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (12) : 1232 - +
  • [24] First interim analysis of the SirTac trial: A randomized phase II study of SIRT and DSMTACE in patients with liver metastases from uveal melanoma.
    Peuker, Caroline-Anna Anna
    De Bucourt, Maximilian
    Gebauer, Bernhard
    Amthauer, Holger
    Erxleben, Christoph
    Eucker, Jan
    Keller, Ulrich
    Leyvraz, Serge
    Joussen, Antonia M.
    Keilholz, Ulrich
    Ochsenreither, Sebastian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [25] The effect of perfusate buffering on toxicity and response in isolated hepatic perfusion for uveal melanoma liver metastases
    Ben-Shabat, Ilan
    Belgrano, Valerio
    Hansson, Christoffer
    Bagge, Roger Olofsson
    [J]. INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2017, 33 (04) : 483 - 488
  • [26] Percutaneous hepatic perfusion as treatment for liver-dominant metastatic uveal melanoma: the first results from a Nordic referral center
    Wong, Andrew
    Huibers, Anne
    Bagge, Roger Olofsson
    [J]. BRITISH JOURNAL OF SURGERY, 2024, 111
  • [27] Radioembolization for treatment of uveal melanoma hepatic metastasis: Results of a phase II, single institution, prospective trial
    Gonsalves, Carin F.
    Eschelman, David J.
    Adamo, Robert D.
    Anne, P. Rani
    Orloff, Marlana M.
    Sato, Takami
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] A Prospective Phase II Trial of Radioembolization for Treatment of Uveal Melanoma Hepatic Metastasis
    Gonsalves, Carin F.
    Eschelman, David J.
    Adamo, Robert D.
    Anne, P. Rani
    Orloff, Marlana M.
    Terai, Mizue
    Hage, Anthony N.
    Yi, Misung
    Chervoneva, Inna
    Sato, Takami
    [J]. RADIOLOGY, 2019, 293 (01) : 223 - 231
  • [29] Treatment with tumor-infiltrating lymphocytes (TIL) versus ipilimumab for advanced melanoma: Results from a multicenter, randomized phase III trial
    Haanen, J. B. A. G.
    Rohaan, M.
    Borch, T. H.
    Van den Berg, J. H.
    Met, Ö.
    Foppen, M. Geukes
    Granhoj, J. Stoltenborg
    Nuijen, B.
    Nijenhuis, C.
    Beijnen, J. H.
    Jedema, I.
    Van Zon, M.
    Noringriis, I. Mansfield
    Kessels, R.
    Wilgenhof, S.
    Van Thienen, H. V.
    Lalezari, F.
    Van Akkooi, A. C. J.
    Donia, M.
    Svane, I-M.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1406 - S1406
  • [30] RANDOMIZED CONTROLLED TRIAL ON THE TREATMENT OF MULTIPLE COLORECTAL LIVER METASTASES
    HUNT, T
    FLOWERDEW, A
    BIRCH, S
    MULLEE, M
    TAYLOR, I
    [J]. GUT, 1989, 30 (10) : A1516 - A1516
12345